Treatment of Anorexia with Unani medicine Habb-e-Tinkar

Clinical Validation of Unani Pharmacopoeal formulation Habb-e-Tinkar in Zofe Ishtiha (Anorexia)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015468

Enrollment

240

Registered

2018-08-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R630- Anorexia Health Condition 2: null- Zofe Ishtiha (Anorexia)

Interventions

Intervention1: Habb-e-Tinkar: Hab-e-Tinkar Pill (250 mg 2 tabs each) Twice daily Oral To be taken with water after meals for two weeks Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of any sex in the age group 19-65 years 2. Patients having Zuâ??f al-IshtihÄ?â?? (Anorexia) with SNAQ score

Exclusion criteria

Exclusion criteria: 1. Patients having Anorexia nervosa 2. Patients having any systemic disease, chronic debilitating disease, T.B., Diabetes Mellitus etc. 3. Known cases of Hepatic, Renal or Cardiac Ailments 4. History of hypersensitivity to study drug or any of its ingredients. 5. History of addiction (Alcohol, Drugs) 6. Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Improvement in the sign and symptoms of Zofe Ishtiha (Anorexia)Timepoint: 2 weeks	—

Secondary

Measure	Time frame
Hematological and biochemical assessments for safetyTimepoint: 2 weeks	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026